Trial
NCT00177866
Safety of Celecoxib in Patients With Crohn's Disease
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Pittsburgh
Collaborators
Shadyside Hospital Foundation; Pfizer
Condition
Crohn's Disease
Intervention
Celebrex
Why stopped
We were unable to get additional funding to complete study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-08-29